Laurie E Steffen1, Kevin E Vowles2, Bruce W Smith2, Gregory N Gan3, Martin J Edelman4. 1. Social Sciences & Health Policy, Wake Forest School of Medicine. 2. Department of Psychology, University of New Mexico. 3. Department of Internal Medicine, Section of Radiation Oncology University of New Mexico Comprehensive Cancer Center. 4. Department of Hematology/Oncology Fox Chase Cancer Center.
Abstract
OBJECTIVE: Given its lethality, associated stigma, and symptom burden, a lung cancer diagnosis poses a substantial challenge for patients. The goal of this study was to examine how daily hope, defined as goal-directed effort and planning to meet goals, and daily stigma were related to same- and next-day functioning in lung cancer patients receiving cancer treatment. METHODS: Fifty lung cancer patients (39 non-small-cell stages IIIa-IV; 11 limited and extensive small cell) completed a baseline questionnaire and 21 daily diaries (n = 1,042) assessing hope, stigma, physical symptoms, treatment factors, and functioning. Hypotheses were tested in same- and next-day models with multilevel modeling. RESULTS: Patients who reported more daily hope reported higher social and role functioning in same- and next-day models. On days that patients reported more hope than usual (compared with their own across-day average), they had higher social, role, and physical functioning; this effect did not carry into the next day. Treatment days were associated with lower social and role functioning when patients reported lower hope and associated with higher functioning when patients reported higher hope. Within-person hope was not predicted by disease symptoms. On days that patients reported more stigma than usual, they reported lower social and role functioning. CONCLUSIONS: Hope is associated with functioning in lung cancer patients, regardless of physical symptoms from disease and treatment. Hope and stigma may therefore be appropriate intervention targets to support daily social and role functioning during lung cancer treatment. (PsycINFO Database Record (c) 2018 APA, all rights reserved).
OBJECTIVE: Given its lethality, associated stigma, and symptom burden, a lung cancer diagnosis poses a substantial challenge for patients. The goal of this study was to examine how daily hope, defined as goal-directed effort and planning to meet goals, and daily stigma were related to same- and next-day functioning in lung cancerpatients receiving cancer treatment. METHODS: Fifty lung cancerpatients (39 non-small-cell stages IIIa-IV; 11 limited and extensive small cell) completed a baseline questionnaire and 21 daily diaries (n = 1,042) assessing hope, stigma, physical symptoms, treatment factors, and functioning. Hypotheses were tested in same- and next-day models with multilevel modeling. RESULTS:Patients who reported more daily hope reported higher social and role functioning in same- and next-day models. On days that patients reported more hope than usual (compared with their own across-day average), they had higher social, role, and physical functioning; this effect did not carry into the next day. Treatment days were associated with lower social and role functioning when patients reported lower hope and associated with higher functioning when patients reported higher hope. Within-person hope was not predicted by disease symptoms. On days that patients reported more stigma than usual, they reported lower social and role functioning. CONCLUSIONS: Hope is associated with functioning in lung cancerpatients, regardless of physical symptoms from disease and treatment. Hope and stigma may therefore be appropriate intervention targets to support daily social and role functioning during lung cancer treatment. (PsycINFO Database Record (c) 2018 APA, all rights reserved).
Authors: C R Snyder; C Harris; J R Anderson; S A Holleran; L M Irving; S T Sigmon; L Yoshinobu; J Gibb; C Langelle; P Harney Journal: J Pers Soc Psychol Date: 1991-04
Authors: Lee W Jones; Whitney E Hornsby; Amy Goetzinger; Lindsay M Forbes; Emily L Sherrard; Morten Quist; Amy T Lane; Miranda West; Neil D Eves; Margaret Gradison; April Coan; James E Herndon; Amy P Abernethy Journal: Lung Cancer Date: 2011-11-22 Impact factor: 5.705
Authors: Wendy W T Lam; Winnie Yeo; Joyce Suen; Wing Ming Ho; Janice Tsang; Inda Soong; Tze Kok Yau; Ka Yan Wong; Wing Kin Sze; Alice W Y Ng; Ava Kwong; Dacita Suen; Daniel Fong; Samuel Ho; Richard Fielding Journal: Psychooncology Date: 2015-06-18 Impact factor: 3.894
Authors: N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes Journal: J Natl Cancer Inst Date: 1993-03-03 Impact factor: 13.506
Authors: Lisa M Thornton; Jennifer S Cheavens; Carolyn A Heitzmann; Caroline S Dorfman; Salene M Wu; Barbara L Andersen Journal: J Consult Clin Psychol Date: 2014-06-02
Authors: S K Chambers; B A Morris; S Clutton; E Foley; L Giles; P Schofield; D O'Connell; J Dunn Journal: Eur J Cancer Care (Engl) Date: 2014-07-23 Impact factor: 2.520
Authors: Laurie E Steffen; Jennifer S Cheavens; Kevin E Vowles; Jennifer Gabbard; Huynh Nguyen; Gregory N Gan; Martin J Edelman; Bruce W Smith Journal: Support Care Cancer Date: 2019-06-01 Impact factor: 3.603
Authors: Jamie S Ostroff; Kristen E Riley; Megan J Shen; Thomas M Atkinson; Timothy J Williamson; Heidi A Hamann Journal: Psychooncology Date: 2019-04-16 Impact factor: 3.894
Authors: Heidi A Hamann; Elizabeth S Ver Hoeve; Lisa Carter-Harris; Jamie L Studts; Jamie S Ostroff Journal: J Thorac Oncol Date: 2018-05-23 Impact factor: 15.609
Authors: Dannielle E Kelley; Erin E Kent; Kristin Litzelman; Michelle A Mollica; Julia H Rowland Journal: Psychooncology Date: 2019-05-08 Impact factor: 3.894
Authors: Laurie E McLouth; Kaitlyn Weyman; Shannon L Golden; Jennifer S Cheavens; Amy Peterman; Vilma Bursac; Jennifer Gabbard; Kathryn E Weaver Journal: Psychooncology Date: 2021-02-26 Impact factor: 3.955